QbDVision

Your AI gave you the right answer. But did it give you the whole answer? In pharma, missing one critical process parameter or supporting study can change everything, yet most AI benchmarks don't measure what matters most in CMC. So how do you know if your AI is actually reliable? Our QbDVision team went beyond generic benchmarks to measure the performance of our own AI, Qurio, against real CMC tasks and expert-verified ground truth. 🎥 Jack Morel breaks down why this matters. Read the article here: https://lnkd.in/gFJNdtq5 #PharmaAI #DigitalCMC #AIBenchmarksForPharma

What does it actually take to build scalable AI for CMC? AI only works when information is structured and contextualized. But in CMC, critical knowledge is still largely locked in PDFs, spreadsheets, and disconnected systems. That’s why we’re building differently. QbDVision provides the structured Digital CMC foundation, while Amazon Web Services (AWS) and Amazon Bedrock provide the secure, scalable infrastructure helping us turn that foundation into AI capabilities designed for regulated CMC. And trust requires more than good outputs. It requires AI that can be measured, evaluated, and governed. With performance grounded in the CMC data and context behind every result. In a new article from AWS, our team shares how we’re using AWS and Amazon Bedrock to make this vision a reality. 👉 Read the AWS story: https://lnkd.in/e6ysQFWk 👉 Explore AI at QbDVision: https://lnkd.in/eyvCXmPf #DigitalCMC #AIforCMC #LifeSciences #Pharma #AWSPartner

Leading gene therapy CDMO Viralgen partnered with QbDVision to cut sponsor onboarding timelines by standardizing data and consolidating platform knowledge. Learn how in Cell & Gene’s new white paper.

Ever feel like your tech transfer process is stuck in the 1400s? Resistance to change isn’t anything new. But don’t let your love of quills hold you back. Digital Tech Transfer in QbDVision eliminates up to 80% of tech transfer-related meetings and up to 100% of scrolls. Ready for your own historic transformation? Go digital: https://lnkd.in/gbvxnB5C #HistoricallyBadTakes #QbDVision #DigitalCMC #DocFreePharma

The FDA is going all-in on AI. But they're also raising the bar on how CMC teams prove their models actually know what they're talking about. GenAI won't deliver regulatory-ready outputs by chewing through unstructured data lakes. It needs structured, traceable CMC knowledge — and the FDA's latest guidance makes that clear. Our latest blog post breaks down what "knowledge-first AI" really means for CMC, and why the foundation you build today determines whether AI works for you tomorrow.

How did Viralgen utilize QbDVision to transform their CDMO partner onboarding process and cut tech transfer timelines from 6-12 months to 3 months? Find out in our latest case study. What’s inside: • How using a pre-built process platform and structured QTPP and CQA templates compressed timelines without compromising quality • How QbDVision became the single source of truth that enabled real-time collaboration and alignment between stakeholders • Why this shift from a document-centric approach to a knowledge-centric model sets a new standard for CDMO partnerships